LifeStance Health Group (NASDAQ:LFST) Stock Price Expected to Rise, BTIG Research Analyst Says

LifeStance Health Group (NASDAQ:LFST) had its price target upped by analysts at BTIG Research from $10.00 to $11.00 in a research report issued to clients and investors on Monday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. BTIG Research’s target price would suggest a potential upside of 54.71% from the stock’s previous close.

Other analysts have also recently issued research reports about the stock. Barclays assumed coverage on shares of LifeStance Health Group in a research note on Tuesday, December 9th. They set an “overweight” rating and a $8.00 target price for the company. Weiss Ratings reiterated a “sell (d-)” rating on shares of LifeStance Health Group in a research note on Monday, December 29th. BMO Capital Markets started coverage on LifeStance Health Group in a report on Thursday, November 13th. They set an “outperform” rating and a $8.00 target price for the company. Wall Street Zen lowered LifeStance Health Group from a “buy” rating to a “hold” rating in a research note on Saturday. Finally, Zacks Research cut LifeStance Health Group from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, November 5th. Two research analysts have rated the stock with a Strong Buy rating, five have assigned a Buy rating, one has given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, LifeStance Health Group presently has a consensus rating of “Moderate Buy” and a consensus target price of $9.00.

LifeStance Health Group Stock Down 1.0%

LifeStance Health Group stock opened at $7.11 on Monday. The stock has a market capitalization of $2.77 billion, a PE ratio of -237.00 and a beta of 1.12. LifeStance Health Group has a 12 month low of $3.74 and a 12 month high of $8.30. The business has a 50 day simple moving average of $7.00 and a 200-day simple moving average of $5.86. The company has a debt-to-equity ratio of 0.18, a current ratio of 1.58 and a quick ratio of 1.58.

LifeStance Health Group (NASDAQ:LFST) last announced its earnings results on Wednesday, November 5th. The company reported $0.02 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.01) by $0.03. The firm had revenue of $363.81 million for the quarter, compared to analyst estimates of $355.06 million. LifeStance Health Group had a negative return on equity of 0.62% and a negative net margin of 0.67%.The business’s revenue was up 16.3% on a year-over-year basis. During the same quarter last year, the firm posted ($0.02) EPS. On average, analysts anticipate that LifeStance Health Group will post -0.18 EPS for the current fiscal year.

Insider Buying and Selling

In other LifeStance Health Group news, Director Robert Bessler sold 119,942 shares of the business’s stock in a transaction on Friday, December 19th. The stock was sold at an average price of $7.04, for a total transaction of $844,391.68. Following the transaction, the director owned 1,318,983 shares of the company’s stock, valued at approximately $9,285,640.32. The trade was a 8.34% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Lisa K. Miller sold 57,240 shares of the firm’s stock in a transaction on Friday, November 21st. The stock was sold at an average price of $6.43, for a total value of $368,053.20. Following the completion of the sale, the insider directly owned 261,292 shares of the company’s stock, valued at $1,680,107.56. This trade represents a 17.97% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders have sold 327,326 shares of company stock worth $2,259,317. 6.60% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On LifeStance Health Group

Institutional investors have recently bought and sold shares of the company. Bayesian Capital Management LP purchased a new stake in shares of LifeStance Health Group in the 2nd quarter valued at approximately $52,000. Blair William & Co. IL acquired a new position in LifeStance Health Group in the second quarter valued at approximately $70,000. Public Employees Retirement System of Ohio purchased a new position in LifeStance Health Group in the second quarter worth approximately $70,000. Vanguard Personalized Indexing Management LLC purchased a new position in LifeStance Health Group in the third quarter worth approximately $72,000. Finally, CIBC Bancorp USA Inc. acquired a new stake in LifeStance Health Group during the third quarter worth $78,000. 85.50% of the stock is owned by hedge funds and other institutional investors.

About LifeStance Health Group

LifeStance Health Group (NASDAQ:LFST) is a leading provider of outpatient mental health services in the United States. Headquartered in New York City, the company operates a growing network of clinics that deliver integrated, patient-centered psychological and psychiatric care. LifeStance’s mission is to expand access to high-quality mental health treatment by combining evidence-based therapy modalities with personalized treatment plans.

The company’s service offerings include individual, family, and group psychotherapy, psychiatric medication management, psychological assessment, and telehealth services.